Global NAD+ Enhancer Market Growth (Status and Outlook) 2026-2032
The global NAD+ Enhancer market size is predicted to grow from US$ 251 million in 2025 to US$ 729 million in 2032; it is expected to grow at a CAGR of 17.1% from 2026 to 2032.
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in all living cells. It plays a crucial role in various biological processes, including energy metabolism, DNA repair, and gene expression. Some people are interested in NAD+ enhancers, which are substances or compounds that may support or increase the levels of NAD+ in the body.
High-purity NAD+ products dominate market demand
Health supplements represent the major application area
NMN is a key NAD+ precursor ingredient
Anti-aging demand drives market attention
Global brands expand NAD+ product adoption
By application, NAD+ Enhancers are mainly used in Health Supplements, Beauty Products, and Others. Health Supplements represent the primary application area, supported by consumer demand for healthy aging, energy metabolism support, and daily wellness management. Beauty Products are an emerging application field driven by anti-aging skincare concepts and beauty-from-within trends. Other applications include functional foods, research-related products, and specialized health management solutions.
This Insight Report provides a comprehensive analysis of the global NAD+ Enhancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on NAD+ Enhancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NAD+ Enhancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NAD+ Enhancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NAD+ Enhancer.
This report presents a comprehensive overview, market shares, and growth opportunities of NAD+ Enhancer market by product type, application, key players and key regions and countries.
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in all living cells. It plays a crucial role in various biological processes, including energy metabolism, DNA repair, and gene expression. Some people are interested in NAD+ enhancers, which are substances or compounds that may support or increase the levels of NAD+ in the body.
Key Findings
The sales of NAD+ Enhancer is about 9.4 tonsHigh-purity NAD+ products dominate market demand
Health supplements represent the major application area
NMN is a key NAD+ precursor ingredient
Anti-aging demand drives market attention
Global brands expand NAD+ product adoption
Market Trends
The NAD+ Enhancer market is developing toward higher purity products, diversified formulations, and broader consumer applications. With increasing interest in cellular health and aging management, manufacturers are expanding product forms from capsules and tablets to functional foods, beauty supplements, and personalized nutrition products. Future market development will depend on scientific validation, product differentiation, and consumer education.Market Dynamics
Drivers
Growing demand for healthy aging, increasing consumer focus on preventive healthcare, and rising interest in functional nutrition are key factors driving NAD+ Enhancer market growth. The expansion of anti-aging consumption and increasing acceptance of nutritional supplements provide favorable conditions for NAD+ related products.Restraints
The market faces challenges including differences in regulatory policies across regions, limited consumer awareness of NAD+ mechanisms, and the need for stronger scientific evidence supporting product benefits. In addition, competition among ingredient suppliers and finished product brands may increase market pressure.Opportunities
The development of personalized nutrition, beauty health products, and premium dietary supplements creates new opportunities for NAD+ Enhancers. Expansion into emerging markets and integration with broader health management solutions may further increase market potential.Challenges
The industry faces challenges related to regulatory compliance, product standardization, scientific research validation, and maintaining consumer trust. Companies need to strengthen quality control, research capabilities, and brand development to achieve sustainable growth.Industry Chain Analysis
The NAD+ Enhancer industry chain includes upstream raw material suppliers providing NMN, NR, nicotinamide, enzymes, and related compounds; midstream manufacturers producing NAD+ supplement products; and downstream brands, distributors, and retailers responsible for market promotion and sales. The industry chain involves biotechnology, nutrition, healthcare, and consumer product sectors.Value Chain Analysis
The value chain covers raw material development, ingredient manufacturing, formulation design, product manufacturing, branding, distribution, and consumer services. High-value segments are mainly concentrated in high-purity ingredient production, product innovation, and brand marketing, where companies with technological advantages and strong market channels have greater competitiveness.Segment Insights
By product purity, NAD+ Enhancers can be classified into Purity <98% and Purity ?98%. Products with purity ?98% represent the mainstream market segment due to higher quality requirements from manufacturers and consumers, particularly in premium health supplement applications. Lower purity products are mainly used in cost-sensitive applications and specific formulations where purity requirements are relatively lower.By application, NAD+ Enhancers are mainly used in Health Supplements, Beauty Products, and Others. Health Supplements represent the primary application area, supported by consumer demand for healthy aging, energy metabolism support, and daily wellness management. Beauty Products are an emerging application field driven by anti-aging skincare concepts and beauty-from-within trends. Other applications include functional foods, research-related products, and specialized health management solutions.
Downstream Market Opportunities
The main downstream opportunities for NAD+ Enhancers come from the expansion of functional nutrition, anti-aging consumption, and personalized health management. As consumers increasingly focus on long-term wellness and preventive health, NAD+ related products are expected to gain broader adoption through supplement brands, beauty products, and integrated health solutions.Regional Insights
North America, Asia-Pacific, and Europe are key regions for NAD+ Enhancer market development. North America benefits from mature dietary supplement consumption and strong demand for anti-aging products. Asia-Pacific has significant growth potential due to expanding health awareness, manufacturing capabilities, and increasing demand for functional nutrition products. Europe shows steady development supported by premium health product consumption.Competitive Landscape Analysis
The NAD+ Enhancer market includes ingredient suppliers, supplement manufacturers, health product brands, and distribution companies. Competition mainly focuses on raw material quality, production technology, product formulation, brand influence, and distribution capabilities. Companies with strong supply chain integration, product innovation capabilities, and global market channels are expected to maintain competitive advantages.Report Scope
LPI (LP Information)' newest research report, the “NAD+ Enhancer Industry Forecast” looks at past sales and reviews total world NAD+ Enhancer sales in 2025, providing a comprehensive analysis by region and market sector of projected NAD+ Enhancer sales for 2026 through 2032. With NAD+ Enhancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NAD+ Enhancer industry.This Insight Report provides a comprehensive analysis of the global NAD+ Enhancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on NAD+ Enhancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NAD+ Enhancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NAD+ Enhancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NAD+ Enhancer.
This report presents a comprehensive overview, market shares, and growth opportunities of NAD+ Enhancer market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Type:
- Content ?98%
- Content ?98%
Segmentation by Form:
- Powder
- Liquid
- Others
Segmentation by Ingestion Method:
- Dietary Supplements
- Pharmaceutical Drugs
- Functional Foods & Beverages
- IV Infusion Products
- Others
Segmentation by Application:
- Health Care Products
- ClinicsBeauty Products
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Niagen Bioscience, Inc.
- Kingdomway
- GeneHarbor
- CELFULL
- EffePharm
- Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
- Herbalmax Inc.
- NOMON Co., Ltd. (Teijin Limited)
- Bontac Bio-Engineering
- ABON Biopharm (ABON Chemical)
- Genex Formulas
- Maac10 Formulas
- Sunhealth Biotech
- Kangying Hongmei (Kang Ying Red Berry)
- Elysium Health, Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NAD+ Enhancer Market Size (2021-2032)
2.1.2 NAD+ Enhancer Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for NAD+ Enhancer by Country/Region (2021, 2025 & 2032)
2.2 NAD+ Enhancer Segment by Type
2.2.1 Content ?98%
2.2.2 Content ?98%
2.2.3 NAD+ Enhancer Market Size by Type
2.2.3.1 NAD+ Enhancer Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global NAD+ Enhancer Market Size Market Share by Type (2021-2026)
2.3 NAD+ Enhancer Segment by Form
2.3.1 Powder
2.3.2 Liquid
2.3.3 Others
2.3.4 NAD+ Enhancer Market Size by Form
2.3.4.1 NAD+ Enhancer Market Size CAGR by Form (2021 VS 2025 VS 2032)
2.3.4.2 Global NAD+ Enhancer Market Size Market Share by Form (2021-2026)
2.4 NAD+ Enhancer Segment by Ingestion Method
2.4.1 Dietary Supplements
2.4.2 Pharmaceutical Drugs
2.4.3 Functional Foods & Beverages
2.4.4 IV Infusion Products
2.4.5 Others
2.4.6 NAD+ Enhancer Market Size by Ingestion Method
2.4.6.1 NAD+ Enhancer Market Size CAGR by Ingestion Method (2021 VS 2025 VS 2032)
2.4.6.2 Global NAD+ Enhancer Market Size Market Share by Ingestion Method (2021-2026)
2.5 NAD+ Enhancer Segment by Application
2.5.1 Health Care Products
2.5.2 ClinicsBeauty Products
2.5.3 Others
2.5.4 NAD+ Enhancer Market Size by Application
2.5.4.1 NAD+ Enhancer Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global NAD+ Enhancer Market Size Market Share by Application (2021-2026)
3 NAD+ ENHANCER MARKET SIZE BY PLAYER
3.1 NAD+ Enhancer Market Size Market Share by Player
3.1.1 Global NAD+ Enhancer Revenue by Player (2021-2026)
3.1.2 Global NAD+ Enhancer Revenue Market Share by Player (2021-2026)
3.2 Global NAD+ Enhancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NAD+ ENHANCER BY REGION
4.1 NAD+ Enhancer Market Size by Region (2021-2026)
4.2 Global NAD+ Enhancer Annual Revenue by Country/Region (2021-2026)
4.3 Americas NAD+ Enhancer Market Size Growth (2021-2026)
4.4 APAC NAD+ Enhancer Market Size Growth (2021-2026)
4.5 Europe NAD+ Enhancer Market Size Growth (2021-2026)
4.6 Middle East & Africa NAD+ Enhancer Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas NAD+ Enhancer Market Size by Country (2021-2026)
5.2 Americas NAD+ Enhancer Market Size by Type (2021-2026)
5.3 Americas NAD+ Enhancer Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NAD+ Enhancer Market Size by Region (2021-2026)
6.2 APAC NAD+ Enhancer Market Size by Type (2021-2026)
6.3 APAC NAD+ Enhancer Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe NAD+ Enhancer Market Size by Country (2021-2026)
7.2 Europe NAD+ Enhancer Market Size by Type (2021-2026)
7.3 Europe NAD+ Enhancer Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NAD+ Enhancer by Region (2021-2026)
8.2 Middle East & Africa NAD+ Enhancer Market Size by Type (2021-2026)
8.3 Middle East & Africa NAD+ Enhancer Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NAD+ ENHANCER MARKET FORECAST
10.1 Global NAD+ Enhancer Forecast by Region (2027-2032)
10.1.1 Global NAD+ Enhancer Forecast by Region (2027-2032)
10.1.2 Americas NAD+ Enhancer Forecast
10.1.3 APAC NAD+ Enhancer Forecast
10.1.4 Europe NAD+ Enhancer Forecast
10.1.5 Middle East & Africa NAD+ Enhancer Forecast
10.2 Americas NAD+ Enhancer Forecast by Country (2027-2032)
10.2.1 United States Market NAD+ Enhancer Forecast
10.2.2 Canada Market NAD+ Enhancer Forecast
10.2.3 Mexico Market NAD+ Enhancer Forecast
10.2.4 Brazil Market NAD+ Enhancer Forecast
10.3 APAC NAD+ Enhancer Forecast by Region (2027-2032)
10.3.1 China NAD+ Enhancer Market Forecast
10.3.2 Japan Market NAD+ Enhancer Forecast
10.3.3 Korea Market NAD+ Enhancer Forecast
10.3.4 Southeast Asia Market NAD+ Enhancer Forecast
10.3.5 India Market NAD+ Enhancer Forecast
10.3.6 Australia Market NAD+ Enhancer Forecast
10.4 Europe NAD+ Enhancer Forecast by Country (2027-2032)
10.4.1 Germany Market NAD+ Enhancer Forecast
10.4.2 France Market NAD+ Enhancer Forecast
10.4.3 UK Market NAD+ Enhancer Forecast
10.4.4 Italy Market NAD+ Enhancer Forecast
10.4.5 Russia Market NAD+ Enhancer Forecast
10.5 Middle East & Africa NAD+ Enhancer Forecast by Region (2027-2032)
10.5.1 Egypt Market NAD+ Enhancer Forecast
10.5.2 South Africa Market NAD+ Enhancer Forecast
10.5.3 Israel Market NAD+ Enhancer Forecast
10.5.4 Turkey Market NAD+ Enhancer Forecast
10.6 Global NAD+ Enhancer Forecast by Type (2027-2032)
10.7 Global NAD+ Enhancer Forecast by Application (2027-2032)
10.7.1 GCC Countries Market NAD+ Enhancer Forecast
11 KEY PLAYERS ANALYSIS
11.1 Niagen Bioscience, Inc.
11.1.1 Niagen Bioscience, Inc. Company Information
11.1.2 Niagen Bioscience, Inc. NAD+ Enhancer Product Offered
11.1.3 Niagen Bioscience, Inc. NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Niagen Bioscience, Inc. Main Business Overview
11.1.5 Niagen Bioscience, Inc. Latest Developments
11.2 Kingdomway
11.2.1 Kingdomway Company Information
11.2.2 Kingdomway NAD+ Enhancer Product Offered
11.2.3 Kingdomway NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Kingdomway Main Business Overview
11.2.5 Kingdomway Latest Developments
11.3 GeneHarbor
11.3.1 GeneHarbor Company Information
11.3.2 GeneHarbor NAD+ Enhancer Product Offered
11.3.3 GeneHarbor NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 GeneHarbor Main Business Overview
11.3.5 GeneHarbor Latest Developments
11.4 CELFULL
11.4.1 CELFULL Company Information
11.4.2 CELFULL NAD+ Enhancer Product Offered
11.4.3 CELFULL NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 CELFULL Main Business Overview
11.4.5 CELFULL Latest Developments
11.5 EffePharm
11.5.1 EffePharm Company Information
11.5.2 EffePharm NAD+ Enhancer Product Offered
11.5.3 EffePharm NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 EffePharm Main Business Overview
11.5.5 EffePharm Latest Developments
11.6 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
11.6.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information
11.6.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product Offered
11.6.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Main Business Overview
11.6.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Latest Developments
11.7 Herbalmax Inc.
11.7.1 Herbalmax Inc. Company Information
11.7.2 Herbalmax Inc. NAD+ Enhancer Product Offered
11.7.3 Herbalmax Inc. NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Herbalmax Inc. Main Business Overview
11.7.5 Herbalmax Inc. Latest Developments
11.8 NOMON Co., Ltd. (Teijin Limited)
11.8.1 NOMON Co., Ltd. (Teijin Limited) Company Information
11.8.2 NOMON Co., Ltd. (Teijin Limited) NAD+ Enhancer Product Offered
11.8.3 NOMON Co., Ltd. (Teijin Limited) NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 NOMON Co., Ltd. (Teijin Limited) Main Business Overview
11.8.5 NOMON Co., Ltd. (Teijin Limited) Latest Developments
11.9 Bontac Bio-Engineering
11.9.1 Bontac Bio-Engineering Company Information
11.9.2 Bontac Bio-Engineering NAD+ Enhancer Product Offered
11.9.3 Bontac Bio-Engineering NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Bontac Bio-Engineering Main Business Overview
11.9.5 Bontac Bio-Engineering Latest Developments
11.10 ABON Biopharm (ABON Chemical)
11.10.1 ABON Biopharm (ABON Chemical) Company Information
11.10.2 ABON Biopharm (ABON Chemical) NAD+ Enhancer Product Offered
11.10.3 ABON Biopharm (ABON Chemical) NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 ABON Biopharm (ABON Chemical) Main Business Overview
11.10.5 ABON Biopharm (ABON Chemical) Latest Developments
11.11 Genex Formulas
11.11.1 Genex Formulas Company Information
11.11.2 Genex Formulas NAD+ Enhancer Product Offered
11.11.3 Genex Formulas NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Genex Formulas Main Business Overview
11.11.5 Genex Formulas Latest Developments
11.12 Maac10 Formulas
11.12.1 Maac10 Formulas Company Information
11.12.2 Maac10 Formulas NAD+ Enhancer Product Offered
11.12.3 Maac10 Formulas NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Maac10 Formulas Main Business Overview
11.12.5 Maac10 Formulas Latest Developments
11.13 Sunhealth Biotech
11.13.1 Sunhealth Biotech Company Information
11.13.2 Sunhealth Biotech NAD+ Enhancer Product Offered
11.13.3 Sunhealth Biotech NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Sunhealth Biotech Main Business Overview
11.13.5 Sunhealth Biotech Latest Developments
11.14 Kangying Hongmei (Kang Ying Red Berry)
11.14.1 Kangying Hongmei (Kang Ying Red Berry) Company Information
11.14.2 Kangying Hongmei (Kang Ying Red Berry) NAD+ Enhancer Product Offered
11.14.3 Kangying Hongmei (Kang Ying Red Berry) NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Kangying Hongmei (Kang Ying Red Berry) Main Business Overview
11.14.5 Kangying Hongmei (Kang Ying Red Berry) Latest Developments
11.15 Elysium Health, Inc.
11.15.1 Elysium Health, Inc. Company Information
11.15.2 Elysium Health, Inc. NAD+ Enhancer Product Offered
11.15.3 Elysium Health, Inc. NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Elysium Health, Inc. Main Business Overview
11.15.5 Elysium Health, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NAD+ Enhancer Market Size (2021-2032)
2.1.2 NAD+ Enhancer Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for NAD+ Enhancer by Country/Region (2021, 2025 & 2032)
2.2 NAD+ Enhancer Segment by Type
2.2.1 Content ?98%
2.2.2 Content ?98%
2.2.3 NAD+ Enhancer Market Size by Type
2.2.3.1 NAD+ Enhancer Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global NAD+ Enhancer Market Size Market Share by Type (2021-2026)
2.3 NAD+ Enhancer Segment by Form
2.3.1 Powder
2.3.2 Liquid
2.3.3 Others
2.3.4 NAD+ Enhancer Market Size by Form
2.3.4.1 NAD+ Enhancer Market Size CAGR by Form (2021 VS 2025 VS 2032)
2.3.4.2 Global NAD+ Enhancer Market Size Market Share by Form (2021-2026)
2.4 NAD+ Enhancer Segment by Ingestion Method
2.4.1 Dietary Supplements
2.4.2 Pharmaceutical Drugs
2.4.3 Functional Foods & Beverages
2.4.4 IV Infusion Products
2.4.5 Others
2.4.6 NAD+ Enhancer Market Size by Ingestion Method
2.4.6.1 NAD+ Enhancer Market Size CAGR by Ingestion Method (2021 VS 2025 VS 2032)
2.4.6.2 Global NAD+ Enhancer Market Size Market Share by Ingestion Method (2021-2026)
2.5 NAD+ Enhancer Segment by Application
2.5.1 Health Care Products
2.5.2 ClinicsBeauty Products
2.5.3 Others
2.5.4 NAD+ Enhancer Market Size by Application
2.5.4.1 NAD+ Enhancer Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global NAD+ Enhancer Market Size Market Share by Application (2021-2026)
3 NAD+ ENHANCER MARKET SIZE BY PLAYER
3.1 NAD+ Enhancer Market Size Market Share by Player
3.1.1 Global NAD+ Enhancer Revenue by Player (2021-2026)
3.1.2 Global NAD+ Enhancer Revenue Market Share by Player (2021-2026)
3.2 Global NAD+ Enhancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NAD+ ENHANCER BY REGION
4.1 NAD+ Enhancer Market Size by Region (2021-2026)
4.2 Global NAD+ Enhancer Annual Revenue by Country/Region (2021-2026)
4.3 Americas NAD+ Enhancer Market Size Growth (2021-2026)
4.4 APAC NAD+ Enhancer Market Size Growth (2021-2026)
4.5 Europe NAD+ Enhancer Market Size Growth (2021-2026)
4.6 Middle East & Africa NAD+ Enhancer Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas NAD+ Enhancer Market Size by Country (2021-2026)
5.2 Americas NAD+ Enhancer Market Size by Type (2021-2026)
5.3 Americas NAD+ Enhancer Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NAD+ Enhancer Market Size by Region (2021-2026)
6.2 APAC NAD+ Enhancer Market Size by Type (2021-2026)
6.3 APAC NAD+ Enhancer Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe NAD+ Enhancer Market Size by Country (2021-2026)
7.2 Europe NAD+ Enhancer Market Size by Type (2021-2026)
7.3 Europe NAD+ Enhancer Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NAD+ Enhancer by Region (2021-2026)
8.2 Middle East & Africa NAD+ Enhancer Market Size by Type (2021-2026)
8.3 Middle East & Africa NAD+ Enhancer Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NAD+ ENHANCER MARKET FORECAST
10.1 Global NAD+ Enhancer Forecast by Region (2027-2032)
10.1.1 Global NAD+ Enhancer Forecast by Region (2027-2032)
10.1.2 Americas NAD+ Enhancer Forecast
10.1.3 APAC NAD+ Enhancer Forecast
10.1.4 Europe NAD+ Enhancer Forecast
10.1.5 Middle East & Africa NAD+ Enhancer Forecast
10.2 Americas NAD+ Enhancer Forecast by Country (2027-2032)
10.2.1 United States Market NAD+ Enhancer Forecast
10.2.2 Canada Market NAD+ Enhancer Forecast
10.2.3 Mexico Market NAD+ Enhancer Forecast
10.2.4 Brazil Market NAD+ Enhancer Forecast
10.3 APAC NAD+ Enhancer Forecast by Region (2027-2032)
10.3.1 China NAD+ Enhancer Market Forecast
10.3.2 Japan Market NAD+ Enhancer Forecast
10.3.3 Korea Market NAD+ Enhancer Forecast
10.3.4 Southeast Asia Market NAD+ Enhancer Forecast
10.3.5 India Market NAD+ Enhancer Forecast
10.3.6 Australia Market NAD+ Enhancer Forecast
10.4 Europe NAD+ Enhancer Forecast by Country (2027-2032)
10.4.1 Germany Market NAD+ Enhancer Forecast
10.4.2 France Market NAD+ Enhancer Forecast
10.4.3 UK Market NAD+ Enhancer Forecast
10.4.4 Italy Market NAD+ Enhancer Forecast
10.4.5 Russia Market NAD+ Enhancer Forecast
10.5 Middle East & Africa NAD+ Enhancer Forecast by Region (2027-2032)
10.5.1 Egypt Market NAD+ Enhancer Forecast
10.5.2 South Africa Market NAD+ Enhancer Forecast
10.5.3 Israel Market NAD+ Enhancer Forecast
10.5.4 Turkey Market NAD+ Enhancer Forecast
10.6 Global NAD+ Enhancer Forecast by Type (2027-2032)
10.7 Global NAD+ Enhancer Forecast by Application (2027-2032)
10.7.1 GCC Countries Market NAD+ Enhancer Forecast
11 KEY PLAYERS ANALYSIS
11.1 Niagen Bioscience, Inc.
11.1.1 Niagen Bioscience, Inc. Company Information
11.1.2 Niagen Bioscience, Inc. NAD+ Enhancer Product Offered
11.1.3 Niagen Bioscience, Inc. NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Niagen Bioscience, Inc. Main Business Overview
11.1.5 Niagen Bioscience, Inc. Latest Developments
11.2 Kingdomway
11.2.1 Kingdomway Company Information
11.2.2 Kingdomway NAD+ Enhancer Product Offered
11.2.3 Kingdomway NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Kingdomway Main Business Overview
11.2.5 Kingdomway Latest Developments
11.3 GeneHarbor
11.3.1 GeneHarbor Company Information
11.3.2 GeneHarbor NAD+ Enhancer Product Offered
11.3.3 GeneHarbor NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 GeneHarbor Main Business Overview
11.3.5 GeneHarbor Latest Developments
11.4 CELFULL
11.4.1 CELFULL Company Information
11.4.2 CELFULL NAD+ Enhancer Product Offered
11.4.3 CELFULL NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 CELFULL Main Business Overview
11.4.5 CELFULL Latest Developments
11.5 EffePharm
11.5.1 EffePharm Company Information
11.5.2 EffePharm NAD+ Enhancer Product Offered
11.5.3 EffePharm NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 EffePharm Main Business Overview
11.5.5 EffePharm Latest Developments
11.6 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
11.6.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information
11.6.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product Offered
11.6.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Main Business Overview
11.6.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Latest Developments
11.7 Herbalmax Inc.
11.7.1 Herbalmax Inc. Company Information
11.7.2 Herbalmax Inc. NAD+ Enhancer Product Offered
11.7.3 Herbalmax Inc. NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Herbalmax Inc. Main Business Overview
11.7.5 Herbalmax Inc. Latest Developments
11.8 NOMON Co., Ltd. (Teijin Limited)
11.8.1 NOMON Co., Ltd. (Teijin Limited) Company Information
11.8.2 NOMON Co., Ltd. (Teijin Limited) NAD+ Enhancer Product Offered
11.8.3 NOMON Co., Ltd. (Teijin Limited) NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 NOMON Co., Ltd. (Teijin Limited) Main Business Overview
11.8.5 NOMON Co., Ltd. (Teijin Limited) Latest Developments
11.9 Bontac Bio-Engineering
11.9.1 Bontac Bio-Engineering Company Information
11.9.2 Bontac Bio-Engineering NAD+ Enhancer Product Offered
11.9.3 Bontac Bio-Engineering NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Bontac Bio-Engineering Main Business Overview
11.9.5 Bontac Bio-Engineering Latest Developments
11.10 ABON Biopharm (ABON Chemical)
11.10.1 ABON Biopharm (ABON Chemical) Company Information
11.10.2 ABON Biopharm (ABON Chemical) NAD+ Enhancer Product Offered
11.10.3 ABON Biopharm (ABON Chemical) NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 ABON Biopharm (ABON Chemical) Main Business Overview
11.10.5 ABON Biopharm (ABON Chemical) Latest Developments
11.11 Genex Formulas
11.11.1 Genex Formulas Company Information
11.11.2 Genex Formulas NAD+ Enhancer Product Offered
11.11.3 Genex Formulas NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Genex Formulas Main Business Overview
11.11.5 Genex Formulas Latest Developments
11.12 Maac10 Formulas
11.12.1 Maac10 Formulas Company Information
11.12.2 Maac10 Formulas NAD+ Enhancer Product Offered
11.12.3 Maac10 Formulas NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Maac10 Formulas Main Business Overview
11.12.5 Maac10 Formulas Latest Developments
11.13 Sunhealth Biotech
11.13.1 Sunhealth Biotech Company Information
11.13.2 Sunhealth Biotech NAD+ Enhancer Product Offered
11.13.3 Sunhealth Biotech NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Sunhealth Biotech Main Business Overview
11.13.5 Sunhealth Biotech Latest Developments
11.14 Kangying Hongmei (Kang Ying Red Berry)
11.14.1 Kangying Hongmei (Kang Ying Red Berry) Company Information
11.14.2 Kangying Hongmei (Kang Ying Red Berry) NAD+ Enhancer Product Offered
11.14.3 Kangying Hongmei (Kang Ying Red Berry) NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Kangying Hongmei (Kang Ying Red Berry) Main Business Overview
11.14.5 Kangying Hongmei (Kang Ying Red Berry) Latest Developments
11.15 Elysium Health, Inc.
11.15.1 Elysium Health, Inc. Company Information
11.15.2 Elysium Health, Inc. NAD+ Enhancer Product Offered
11.15.3 Elysium Health, Inc. NAD+ Enhancer Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Elysium Health, Inc. Main Business Overview
11.15.5 Elysium Health, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. NAD+ Enhancer Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. NAD+ Enhancer Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Content ?98%
Table 4. Major Players of Content ?98%
Table 5. NAD+ Enhancer Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global NAD+ Enhancer Market Size by Type (2021-2026) & ($ millions)
Table 7. Global NAD+ Enhancer Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Powder
Table 9. Major Players of Liquid
Table 10. Major Players of Others
Table 11. NAD+ Enhancer Market Size CAGR by Form (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global NAD+ Enhancer Market Size by Form (2021-2026) & ($ millions)
Table 13. Global NAD+ Enhancer Market Size Market Share by Form (2021-2026)
Table 14. Major Players of Dietary Supplements
Table 15. Major Players of Pharmaceutical Drugs
Table 16. Major Players of Functional Foods & Beverages
Table 17. Major Players of IV Infusion Products
Table 18. Major Players of Others
Table 19. NAD+ Enhancer Market Size CAGR by Ingestion Method (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global NAD+ Enhancer Market Size by Ingestion Method (2021-2026) & ($ millions)
Table 21. Global NAD+ Enhancer Market Size Market Share by Ingestion Method (2021-2026)
Table 22. NAD+ Enhancer Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global NAD+ Enhancer Market Size by Application (2021-2026) & ($ millions)
Table 24. Global NAD+ Enhancer Market Size Market Share by Application (2021-2026)
Table 25. Global NAD+ Enhancer Revenue by Player (2021-2026) & ($ millions)
Table 26. Global NAD+ Enhancer Revenue Market Share by Player (2021-2026)
Table 27. NAD+ Enhancer Key Players Head office and Products Offered
Table 28. NAD+ Enhancer Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global NAD+ Enhancer Market Size by Region (2021-2026) & ($ millions)
Table 32. Global NAD+ Enhancer Market Size Market Share by Region (2021-2026)
Table 33. Global NAD+ Enhancer Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global NAD+ Enhancer Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas NAD+ Enhancer Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas NAD+ Enhancer Market Size Market Share by Country (2021-2026)
Table 37. Americas NAD+ Enhancer Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas NAD+ Enhancer Market Size Market Share by Type (2021-2026)
Table 39. Americas NAD+ Enhancer Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas NAD+ Enhancer Market Size Market Share by Application (2021-2026)
Table 41. APAC NAD+ Enhancer Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC NAD+ Enhancer Market Size Market Share by Region (2021-2026)
Table 43. APAC NAD+ Enhancer Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC NAD+ Enhancer Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe NAD+ Enhancer Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe NAD+ Enhancer Market Size Market Share by Country (2021-2026)
Table 47. Europe NAD+ Enhancer Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe NAD+ Enhancer Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa NAD+ Enhancer Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa NAD+ Enhancer Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa NAD+ Enhancer Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of NAD+ Enhancer
Table 53. Key Market Challenges & Risks of NAD+ Enhancer
Table 54. Key Industry Trends of NAD+ Enhancer
Table 55. Global NAD+ Enhancer Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global NAD+ Enhancer Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global NAD+ Enhancer Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global NAD+ Enhancer Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Niagen Bioscience, Inc. Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 60. Niagen Bioscience, Inc. NAD+ Enhancer Product Offered
Table 61. Niagen Bioscience, Inc. NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Niagen Bioscience, Inc. Main Business
Table 63. Niagen Bioscience, Inc. Latest Developments
Table 64. Kingdomway Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 65. Kingdomway NAD+ Enhancer Product Offered
Table 66. Kingdomway NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Kingdomway Main Business
Table 68. Kingdomway Latest Developments
Table 69. GeneHarbor Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 70. GeneHarbor NAD+ Enhancer Product Offered
Table 71. GeneHarbor NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. GeneHarbor Main Business
Table 73. GeneHarbor Latest Developments
Table 74. CELFULL Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 75. CELFULL NAD+ Enhancer Product Offered
Table 76. CELFULL NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. CELFULL Main Business
Table 78. CELFULL Latest Developments
Table 79. EffePharm Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 80. EffePharm NAD+ Enhancer Product Offered
Table 81. EffePharm NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. EffePharm Main Business
Table 83. EffePharm Latest Developments
Table 84. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 85. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product Offered
Table 86. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Main Business
Table 88. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Latest Developments
Table 89. Herbalmax Inc. Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 90. Herbalmax Inc. NAD+ Enhancer Product Offered
Table 91. Herbalmax Inc. NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Herbalmax Inc. Main Business
Table 93. Herbalmax Inc. Latest Developments
Table 94. NOMON Co., Ltd. (Teijin Limited) Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 95. NOMON Co., Ltd. (Teijin Limited) NAD+ Enhancer Product Offered
Table 96. NOMON Co., Ltd. (Teijin Limited) NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. NOMON Co., Ltd. (Teijin Limited) Main Business
Table 98. NOMON Co., Ltd. (Teijin Limited) Latest Developments
Table 99. Bontac Bio-Engineering Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 100. Bontac Bio-Engineering NAD+ Enhancer Product Offered
Table 101. Bontac Bio-Engineering NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Bontac Bio-Engineering Main Business
Table 103. Bontac Bio-Engineering Latest Developments
Table 104. ABON Biopharm (ABON Chemical) Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 105. ABON Biopharm (ABON Chemical) NAD+ Enhancer Product Offered
Table 106. ABON Biopharm (ABON Chemical) NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. ABON Biopharm (ABON Chemical) Main Business
Table 108. ABON Biopharm (ABON Chemical) Latest Developments
Table 109. Genex Formulas Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 110. Genex Formulas NAD+ Enhancer Product Offered
Table 111. Genex Formulas NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Genex Formulas Main Business
Table 113. Genex Formulas Latest Developments
Table 114. Maac10 Formulas Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 115. Maac10 Formulas NAD+ Enhancer Product Offered
Table 116. Maac10 Formulas NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Maac10 Formulas Main Business
Table 118. Maac10 Formulas Latest Developments
Table 119. Sunhealth Biotech Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 120. Sunhealth Biotech NAD+ Enhancer Product Offered
Table 121. Sunhealth Biotech NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Sunhealth Biotech Main Business
Table 123. Sunhealth Biotech Latest Developments
Table 124. Kangying Hongmei (Kang Ying Red Berry) Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 125. Kangying Hongmei (Kang Ying Red Berry) NAD+ Enhancer Product Offered
Table 126. Kangying Hongmei (Kang Ying Red Berry) NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Kangying Hongmei (Kang Ying Red Berry) Main Business
Table 128. Kangying Hongmei (Kang Ying Red Berry) Latest Developments
Table 129. Elysium Health, Inc. Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 130. Elysium Health, Inc. NAD+ Enhancer Product Offered
Table 131. Elysium Health, Inc. NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Elysium Health, Inc. Main Business
Table 133. Elysium Health, Inc. Latest Developments
Table 1. NAD+ Enhancer Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. NAD+ Enhancer Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Content ?98%
Table 4. Major Players of Content ?98%
Table 5. NAD+ Enhancer Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global NAD+ Enhancer Market Size by Type (2021-2026) & ($ millions)
Table 7. Global NAD+ Enhancer Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Powder
Table 9. Major Players of Liquid
Table 10. Major Players of Others
Table 11. NAD+ Enhancer Market Size CAGR by Form (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global NAD+ Enhancer Market Size by Form (2021-2026) & ($ millions)
Table 13. Global NAD+ Enhancer Market Size Market Share by Form (2021-2026)
Table 14. Major Players of Dietary Supplements
Table 15. Major Players of Pharmaceutical Drugs
Table 16. Major Players of Functional Foods & Beverages
Table 17. Major Players of IV Infusion Products
Table 18. Major Players of Others
Table 19. NAD+ Enhancer Market Size CAGR by Ingestion Method (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global NAD+ Enhancer Market Size by Ingestion Method (2021-2026) & ($ millions)
Table 21. Global NAD+ Enhancer Market Size Market Share by Ingestion Method (2021-2026)
Table 22. NAD+ Enhancer Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global NAD+ Enhancer Market Size by Application (2021-2026) & ($ millions)
Table 24. Global NAD+ Enhancer Market Size Market Share by Application (2021-2026)
Table 25. Global NAD+ Enhancer Revenue by Player (2021-2026) & ($ millions)
Table 26. Global NAD+ Enhancer Revenue Market Share by Player (2021-2026)
Table 27. NAD+ Enhancer Key Players Head office and Products Offered
Table 28. NAD+ Enhancer Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global NAD+ Enhancer Market Size by Region (2021-2026) & ($ millions)
Table 32. Global NAD+ Enhancer Market Size Market Share by Region (2021-2026)
Table 33. Global NAD+ Enhancer Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global NAD+ Enhancer Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas NAD+ Enhancer Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas NAD+ Enhancer Market Size Market Share by Country (2021-2026)
Table 37. Americas NAD+ Enhancer Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas NAD+ Enhancer Market Size Market Share by Type (2021-2026)
Table 39. Americas NAD+ Enhancer Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas NAD+ Enhancer Market Size Market Share by Application (2021-2026)
Table 41. APAC NAD+ Enhancer Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC NAD+ Enhancer Market Size Market Share by Region (2021-2026)
Table 43. APAC NAD+ Enhancer Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC NAD+ Enhancer Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe NAD+ Enhancer Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe NAD+ Enhancer Market Size Market Share by Country (2021-2026)
Table 47. Europe NAD+ Enhancer Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe NAD+ Enhancer Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa NAD+ Enhancer Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa NAD+ Enhancer Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa NAD+ Enhancer Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of NAD+ Enhancer
Table 53. Key Market Challenges & Risks of NAD+ Enhancer
Table 54. Key Industry Trends of NAD+ Enhancer
Table 55. Global NAD+ Enhancer Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global NAD+ Enhancer Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global NAD+ Enhancer Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global NAD+ Enhancer Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Niagen Bioscience, Inc. Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 60. Niagen Bioscience, Inc. NAD+ Enhancer Product Offered
Table 61. Niagen Bioscience, Inc. NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Niagen Bioscience, Inc. Main Business
Table 63. Niagen Bioscience, Inc. Latest Developments
Table 64. Kingdomway Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 65. Kingdomway NAD+ Enhancer Product Offered
Table 66. Kingdomway NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Kingdomway Main Business
Table 68. Kingdomway Latest Developments
Table 69. GeneHarbor Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 70. GeneHarbor NAD+ Enhancer Product Offered
Table 71. GeneHarbor NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. GeneHarbor Main Business
Table 73. GeneHarbor Latest Developments
Table 74. CELFULL Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 75. CELFULL NAD+ Enhancer Product Offered
Table 76. CELFULL NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. CELFULL Main Business
Table 78. CELFULL Latest Developments
Table 79. EffePharm Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 80. EffePharm NAD+ Enhancer Product Offered
Table 81. EffePharm NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. EffePharm Main Business
Table 83. EffePharm Latest Developments
Table 84. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 85. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product Offered
Table 86. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Main Business
Table 88. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Latest Developments
Table 89. Herbalmax Inc. Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 90. Herbalmax Inc. NAD+ Enhancer Product Offered
Table 91. Herbalmax Inc. NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Herbalmax Inc. Main Business
Table 93. Herbalmax Inc. Latest Developments
Table 94. NOMON Co., Ltd. (Teijin Limited) Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 95. NOMON Co., Ltd. (Teijin Limited) NAD+ Enhancer Product Offered
Table 96. NOMON Co., Ltd. (Teijin Limited) NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. NOMON Co., Ltd. (Teijin Limited) Main Business
Table 98. NOMON Co., Ltd. (Teijin Limited) Latest Developments
Table 99. Bontac Bio-Engineering Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 100. Bontac Bio-Engineering NAD+ Enhancer Product Offered
Table 101. Bontac Bio-Engineering NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Bontac Bio-Engineering Main Business
Table 103. Bontac Bio-Engineering Latest Developments
Table 104. ABON Biopharm (ABON Chemical) Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 105. ABON Biopharm (ABON Chemical) NAD+ Enhancer Product Offered
Table 106. ABON Biopharm (ABON Chemical) NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. ABON Biopharm (ABON Chemical) Main Business
Table 108. ABON Biopharm (ABON Chemical) Latest Developments
Table 109. Genex Formulas Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 110. Genex Formulas NAD+ Enhancer Product Offered
Table 111. Genex Formulas NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Genex Formulas Main Business
Table 113. Genex Formulas Latest Developments
Table 114. Maac10 Formulas Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 115. Maac10 Formulas NAD+ Enhancer Product Offered
Table 116. Maac10 Formulas NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Maac10 Formulas Main Business
Table 118. Maac10 Formulas Latest Developments
Table 119. Sunhealth Biotech Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 120. Sunhealth Biotech NAD+ Enhancer Product Offered
Table 121. Sunhealth Biotech NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Sunhealth Biotech Main Business
Table 123. Sunhealth Biotech Latest Developments
Table 124. Kangying Hongmei (Kang Ying Red Berry) Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 125. Kangying Hongmei (Kang Ying Red Berry) NAD+ Enhancer Product Offered
Table 126. Kangying Hongmei (Kang Ying Red Berry) NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Kangying Hongmei (Kang Ying Red Berry) Main Business
Table 128. Kangying Hongmei (Kang Ying Red Berry) Latest Developments
Table 129. Elysium Health, Inc. Details, Company Type, NAD+ Enhancer Area Served and Its Competitors
Table 130. Elysium Health, Inc. NAD+ Enhancer Product Offered
Table 131. Elysium Health, Inc. NAD+ Enhancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Elysium Health, Inc. Main Business
Table 133. Elysium Health, Inc. Latest Developments
LIST OF FIGURES
Figure 1. NAD+ Enhancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global NAD+ Enhancer Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. NAD+ Enhancer Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. NAD+ Enhancer Sales Market Share by Country/Region (2025)
Figure 8. NAD+ Enhancer Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global NAD+ Enhancer Market Size Market Share by Type in 2025
Figure 10. Global NAD+ Enhancer Market Size Market Share by Form in 2025
Figure 11. Global NAD+ Enhancer Market Size Market Share by Ingestion Method in 2025
Figure 12. NAD+ Enhancer in Health Care Products
Figure 13. Global NAD+ Enhancer Market: Health Care Products (2021-2026) & ($ millions)
Figure 14. NAD+ Enhancer in ClinicsBeauty Products
Figure 15. Global NAD+ Enhancer Market: ClinicsBeauty Products (2021-2026) & ($ millions)
Figure 16. NAD+ Enhancer in Others
Figure 17. Global NAD+ Enhancer Market: Others (2021-2026) & ($ millions)
Figure 18. Global NAD+ Enhancer Market Size Market Share by Application in 2025
Figure 19. Global NAD+ Enhancer Revenue Market Share by Player in 2025
Figure 20. Global NAD+ Enhancer Market Size Market Share by Region (2021-2026)
Figure 21. Americas NAD+ Enhancer Market Size 2021-2026 ($ millions)
Figure 22. APAC NAD+ Enhancer Market Size 2021-2026 ($ millions)
Figure 23. Europe NAD+ Enhancer Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa NAD+ Enhancer Market Size 2021-2026 ($ millions)
Figure 25. Americas NAD+ Enhancer Value Market Share by Country in 2025
Figure 26. United States NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC NAD+ Enhancer Market Size Market Share by Region in 2025
Figure 31. APAC NAD+ Enhancer Market Size Market Share by Type (2021-2026)
Figure 32. APAC NAD+ Enhancer Market Size Market Share by Application (2021-2026)
Figure 33. China NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 37. India NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe NAD+ Enhancer Market Size Market Share by Country in 2025
Figure 40. Europe NAD+ Enhancer Market Size Market Share by Type (2021-2026)
Figure 41. Europe NAD+ Enhancer Market Size Market Share by Application (2021-2026)
Figure 42. Germany NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 43. France NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 44. UK NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa NAD+ Enhancer Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa NAD+ Enhancer Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa NAD+ Enhancer Market Size Market Share by Application (2021-2026)
Figure 50. Egypt NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 56. APAC NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 57. Europe NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 59. United States NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 60. Canada NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 61. Mexico NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 62. Brazil NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 63. China NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 64. Japan NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 65. Korea NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 67. India NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 68. Australia NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 69. Germany NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 70. France NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 71. UK NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 72. Italy NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 73. Russia NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 74. Egypt NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 75. South Africa NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 76. Israel NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 77. Turkey NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 78. Global NAD+ Enhancer Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global NAD+ Enhancer Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 1. NAD+ Enhancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global NAD+ Enhancer Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. NAD+ Enhancer Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. NAD+ Enhancer Sales Market Share by Country/Region (2025)
Figure 8. NAD+ Enhancer Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global NAD+ Enhancer Market Size Market Share by Type in 2025
Figure 10. Global NAD+ Enhancer Market Size Market Share by Form in 2025
Figure 11. Global NAD+ Enhancer Market Size Market Share by Ingestion Method in 2025
Figure 12. NAD+ Enhancer in Health Care Products
Figure 13. Global NAD+ Enhancer Market: Health Care Products (2021-2026) & ($ millions)
Figure 14. NAD+ Enhancer in ClinicsBeauty Products
Figure 15. Global NAD+ Enhancer Market: ClinicsBeauty Products (2021-2026) & ($ millions)
Figure 16. NAD+ Enhancer in Others
Figure 17. Global NAD+ Enhancer Market: Others (2021-2026) & ($ millions)
Figure 18. Global NAD+ Enhancer Market Size Market Share by Application in 2025
Figure 19. Global NAD+ Enhancer Revenue Market Share by Player in 2025
Figure 20. Global NAD+ Enhancer Market Size Market Share by Region (2021-2026)
Figure 21. Americas NAD+ Enhancer Market Size 2021-2026 ($ millions)
Figure 22. APAC NAD+ Enhancer Market Size 2021-2026 ($ millions)
Figure 23. Europe NAD+ Enhancer Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa NAD+ Enhancer Market Size 2021-2026 ($ millions)
Figure 25. Americas NAD+ Enhancer Value Market Share by Country in 2025
Figure 26. United States NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC NAD+ Enhancer Market Size Market Share by Region in 2025
Figure 31. APAC NAD+ Enhancer Market Size Market Share by Type (2021-2026)
Figure 32. APAC NAD+ Enhancer Market Size Market Share by Application (2021-2026)
Figure 33. China NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 37. India NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe NAD+ Enhancer Market Size Market Share by Country in 2025
Figure 40. Europe NAD+ Enhancer Market Size Market Share by Type (2021-2026)
Figure 41. Europe NAD+ Enhancer Market Size Market Share by Application (2021-2026)
Figure 42. Germany NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 43. France NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 44. UK NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa NAD+ Enhancer Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa NAD+ Enhancer Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa NAD+ Enhancer Market Size Market Share by Application (2021-2026)
Figure 50. Egypt NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries NAD+ Enhancer Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 56. APAC NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 57. Europe NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 59. United States NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 60. Canada NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 61. Mexico NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 62. Brazil NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 63. China NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 64. Japan NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 65. Korea NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 67. India NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 68. Australia NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 69. Germany NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 70. France NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 71. UK NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 72. Italy NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 73. Russia NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 74. Egypt NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 75. South Africa NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 76. Israel NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 77. Turkey NAD+ Enhancer Market Size 2027-2032 ($ millions)
Figure 78. Global NAD+ Enhancer Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global NAD+ Enhancer Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries NAD+ Enhancer Market Size 2027-2032 ($ millions)
